AMENDMENT 2 TO EMPLOYMENT AGREEMENTEmployment Agreement • March 29th, 2004 • Interleukin Genetics Inc • In vitro & in vivo diagnostic substances
THIS AMENDMENT 2 (the “Amendment 2”), dated as of December 11, 2003, is made by and between INTERLEUKIN GENETICS, INC., a Delaware corporation (“Employer”), and FENEL ELOI, an individual (“Employee”). Employer and Employee are parties to an Employment Agreement, dated June 18, 2000 (the “Employment Agreement”) and an Amendment to Employment Agreement, dated March 5, 2003 (the “Amendment”). Terms not otherwise defined in this Amendment 2 shall have the meanings given to them in the Employment Agreement and/or Amendment.
DISTRIBUTION AGREEMENTDistribution Agreement • March 29th, 2004 • Interleukin Genetics Inc • In vitro & in vivo diagnostic substances • Michigan
THIS DISTRIBUTION AGREEMENT (this “Agreement”) is made as of February 26, 2004 (the “Effective Date”), between ACCESS BUSINESS GROUP INTERNATIONAL LLC (“Access”), a Michigan limited liability company with its principal place of business at 7575 East Fulton Road, Ada, Michigan 49355, United States; and INTERLEUKIN GENETICS INC. (“Seller”) a Delaware corporation with its principal place of business at 135 Beaver Street, Waltham, Massachusetts 02452.
COMMERCIAL LEASECommercial Lease • March 29th, 2004 • Interleukin Genetics Inc • In vitro & in vivo diagnostic substances
WHEREAS the Parties hereto are presently Lessor and Lessee under a lease agreement dated June 8, 2001 for 6,011 Square Feet +/- of Premises on the third floor of 135 Beaver St, (‘the Original Lease”) and
